pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,347 catalysts · 5,347 phase readout · 2,315 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 20 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,347
  • 8k filing2,315
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT02652767: Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Sponsor: GenSight Biologics. Phase: PHASE3. Conditions: Optic, Atrophy, Hereditary, Leber

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07606807: rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE3. Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06543407: Harm Reduction for Smokers With Mental Illness

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Tobacco Dependence

full page →ctgov ↗
›RECRUITINGphase readoutNCT05698992: Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer

Sponsor: Region Skane. Phase: . Conditions: Esophageal Cancer, Esophageal Neoplasms, Gastric Cancer, Stomach Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT02838836: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Sponsor: University of Missouri-Columbia. Phase: . Conditions: Non-small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Pancreatic Cancer, Hepatocellular Cancer, Colorectal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03317392: Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07309536: Mediterranean Diet Uptake and Nutrition on Child Health, Inflammation, and Early-life Symbiosis (MUNCHIES) Study

Sponsor: University of New Brunswick. Phase: NA. Conditions: Gut Microbiome, Body Composition, Adherence, Metabolites, Inflammation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06818136: Bladder EpiCheck European Haematuria Study

Sponsor: Nucleix Ltd.. Phase: . Conditions: Hematuria, Cystoscopy, Urothelial Carcinoma Bladder, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma of the Urinary Bladder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07307911: Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy

Sponsor: Damanhour University. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07551011: Impact of Behavioural Modification Working Toolkit Among Women With Gestational Diabetes Mellitus and Hypertension

Sponsor: University of the Punjab. Phase: NA. Conditions: Gestational Diabetes Mellitus in Pregnancy, Hypertension ,Pregnancy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07449611: Comparative Impacts of Two Anesthesia Methods on Peripheral Tissue Oxygenation in the Upper Limb

Sponsor: Sakarya University. Phase: NA. Conditions: Regional Anesthesia, Interscalene Blocks, Shoulder Surgery, Perfusion Index

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT02522611: Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: PHASE1. Conditions: Intractable Pain, Palliative Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT07207707: A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc.. Phase: PHASE1. Conditions: Solid Tumor Malignancies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06114992: Servo-n HFOV Study: Safety and Performance in Neonates and Infants

Sponsor: Maquet Critical Care AB. Phase: . Conditions: Elective HFOV for Respiratory Failure in Neonates/Infants, Rescue HFOV in Neonates and/Infants With Refractory Respiratory Failure Under Conventional Therapy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07330492: Testing a Brief Reassurance Message Before a Musculoskeletal Clinic Visit

Sponsor: University of Texas at Austin. Phase: NA. Conditions: Any Non-traumatic Musculoskeletal Condition

full page →ctgov ↗
›TERMINATEDphase readoutNCT04396236: A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Migraine

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04927650: Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

Sponsor: University of California, San Francisco. Phase: . Conditions: Cervical Carcinoma, Human Papillomavirus-Related Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06502574: Self-Care Management in Older Adults

Sponsor: Sultan Ayaz Alkaya. Phase: NA. Conditions: Disease Self Management

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07591974: Simulation-Based Training on Immediate Newborn Care

Sponsor: University of Baghdad. Phase: NA. Conditions: Newborn Care

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07300891: T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy

Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Refractory Solid Cancer Patients Unexposed to Immunotherapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07037511: Effects of Salbutamol in Athletes and Implications for Screening and Sports

Sponsor: University of British Columbia. Phase: NA. Conditions: Asthma, Healthy, Effect of Drug

full page →ctgov ↗
›RECRUITINGphase readoutNCT07314411: Carotenoid Supplementation and Retinal Health in Healthy Adults

Sponsor: Pacific University. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04401111: One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: . Conditions: COVID, ARDS, Quality of Life

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06247111: Monitoring Blood Pressure at Home

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Hypertension

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07512011: Outcomes of Different Bone Graft Combinations for Maxillary Sinus Augmentation Procedure

Sponsor: Ohio State University. Phase: . Conditions: Bone Grafting, Sinus Lifting

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07606092: Human Tendon Tissue Collection

Sponsor: Queen Mary University of London. Phase: . Conditions: Tendinopathy, Musculoskeletal Diseases or Conditions, ACL Surgery, Achilles Tendon Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT05947136: PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

Sponsor: Centre Leon Berard. Phase: NA. Conditions: Multiple Myeloma, Complication

full page →ctgov ↗
›RECRUITINGphase readoutNCT06326411: A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Sponsor: Nested Therapeutics, Inc. Phase: PHASE1. Conditions: Oncology, MEK Mutation, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation, Melanoma, NSCLC, Glioma, Solid Tumor, Adult, MAPK Pathway Gene Mutation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04554914: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Sponsor: Pierre Fabre Medicament. Phase: PHASE2. Conditions: Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD), EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications, EBV+ Sarcomas, Leiomyosarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT02986516: Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease

Sponsor: Italian Sarcoma Group. Phase: NA. Conditions: Chordoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07485816: A Study on the Correlation Between Cardiac-Cerebral Oxygenation Reserve and Cognitive Function Changes in Heart Failure Patients

Sponsor: Yan'an Affiliated Hospital of Kunming Medical University. Phase: . Conditions: Heart Failure (HF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07585916: Prenatal Yoga Intervention in Pregnant Women

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Pregnant Women, Prenatal Yoga, Trauma, Body Image, Delivery

full page →ctgov ↗
›RECRUITINGphase readoutNCT03611816: Biological Bank for Atrial Fibrillation and Stroke

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Stroke, Atrial Fibrillation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06630416: Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

Sponsor: Northwestern University. Phase: PHASE2. Conditions: Metastatic Bladder Urothelial Carcinoma, Metastatic Malignant Solid Neoplasm, Stage IV Bladder Cancer AJCC v8

full page →ctgov ↗
›COMPLETEDphase readoutNCT03548506: Subthalamic Steering for Therapy Optimization in Parkinson's Disease

Sponsor: University Hospital Tuebingen. Phase: NA. Conditions: Parkinson Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01946204: A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Prostatic Neoplasms

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05454852: Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia

Sponsor: Boston University. Phase: . Conditions: HIV

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07282652: A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy

Sponsor: Peking Union Medical College Hospital. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06718049: Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna. Phase: . Conditions: Systemic Juvenile Idiopathic Arthritis (sJIA)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06952049: Does Psychoeducation Improve the Pain Relief Derived From a Brief Intervention

Sponsor: Florida State University. Phase: NA. Conditions: Pain, Acute Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07557849: Multicentric Database for KRAS Mutant Pancreatic Cancer

Sponsor: Fudan University. Phase: . Conditions: Pancreatic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07618338: Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia

Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Schizophrenia Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03767348: Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Sponsor: Replimune, Inc.. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07504848: Stroke Mobility and Caregiver Outcomes

Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Stroke, Caregiver

full page →ctgov ↗
›COMPLETEDphase readoutNCT04481048: Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: PHASE2. Conditions: Neurofibromatosis 1

full page →ctgov ↗
›COMPLETEDphase readoutNCT04818255: STIM+: PET Biomarker Education & Disclosure

Sponsor: University of Michigan. Phase: NA. Conditions: Mild Cognitive Impairment, Dementia; Alzheimer's Type (Etiology)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07446855: Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Solid Tumours

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06782126: A Study Protocol for the Implementation and Evaluation of a Self-management Support Program in Burns Aftercare for Burn Survivors in the Netherlands

Sponsor: Martini Hospital Groningen. Phase: . Conditions: Burns

full page →ctgov ↗
›RECRUITINGphase readoutNCT03269578: Sample Collection and Tracking for the Developmental Therapeutics Clinic

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Neoplasms, Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07436585: CGM-Guided Acarbose for Painful Diabetic Neuropathy

Sponsor: Shifa International Hospital. Phase: PHASE1. Conditions: Diabetes, Diabetes Complications, Diabetic Neuropathy

full page →ctgov ↗
← prev
page 49 of 107
next →